Compare $ACUT vs $BCAB | Chartloom

Compare

$ACUT vs $BCAB

Accustem Sciences Inc · Bioatla Inc

ACUT

Accustem Sciences Inc

BCAB

Bioatla Inc

Compare $ACUT vs $BCAB

Comparing Accustem Sciences Inc and Bioatla Inc

ACUTAccustem Sciences Inc

BCABBioatla Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

BCABBioatla Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-22.7%

YTD performance

-94.4%

52W performance

-96.7%

FCF yield

-943.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

BCAB

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BCAB

Bioatla Inc

Market Cap

ACUT$2M

BCAB$2M

Enterprise Value

ACUT$2M

BCAB$946K

Price

ACUT$0.15

BCAB$1.50

P/E Ratio

ACUTN/A

BCABN/A

P/S Ratio

ACUT0.00x

BCAB0.29x

EV/Sales

ACUT0.00x

BCAB0.11x

EV/EBITDA

ACUT0.00x

BCAB0.00x

P/B Ratio

ACUT2.97x

BCAB4.57x

P/FCF Ratio

ACUTN/A

BCABN/A

EV/FCF

ACUT-2.01x

BCAB-0.04x

PEG Ratio

ACUTN/A

BCABN/A

Forward P/E (NTM)

ACUTN/A

BCABN/A

Forward P/S (NTM)

ACUTN/A

BCABN/A

Revenue (TTM)

ACUT$0

BCAB$9M

Revenue Growth (YoY)

ACUTN/A

BCAB-22.7%

Forward Rev Growth

ACUT0.0%

BCAB0.0%

Gross Margin (TTM)

ACUT0.0%

BCAB0.0%

Operating Margin (TTM)

ACUT0.0%

BCAB0.0%

EBITDA Margin (TTM)

ACUT0.0%

BCAB-369.8%

Net Margin (TTM)

ACUT0.0%

BCAB-370.0%

FCF Margin (TTM)

ACUTN/A

BCAB-276.3%

Net Income (TTM)

ACUT$-2M

BCAB$-31M

FCF (TTM)

ACUT$-1M

BCAB$-23M

EPS (TTM)

ACUT-$0.10

BCAB-$18.93

ROE (TTM)

ACUT-21712.9%

BCAB-35792.0%

ROA (TTM)

ACUT-10530.0%

BCAB-26317.0%

ROIC (TTM)

ACUT-179413.5%

BCAB-35792.0%

Cash

ACUT$13K

BCAB$2M

Debt

ACUT$63K

BCAB$0

Net Cash/Debt

ACUT$-50K

BCAB$2M

Current Ratio (TTM)

ACUT0.02x

BCAB0.20x

Quick Ratio (TTM)

ACUT0.00x

BCAB0.17x

Debt/Equity (TTM)

ACUT0.27x

BCAB0.00x

Debt/Assets (TTM)

ACUT0.0%

BCAB0.0%

Interest Coverage (TTM)

ACUTN/A

BCABN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BCAB0.00x

Beta

ACUT1.88

BCAB0.63

52W Performance

ACUT-67.3%

BCAB-96.7%

YTD Performance

ACUT-75.6%

BCAB-94.4%

% from 52W High

ACUT-93.7%

BCAB-97.9%

% from 52W Low

ACUT26.0%

BCAB40.2%

Asset Turnover (TTM)

ACUT0.00x

BCAB0.73x

FCF Yield (TTM)

ACUT-50.9%

BCAB-943.1%

Earnings Yield (TTM)

ACUT-69.8%

BCAB-1263.2%

Dividend Yield (TTM)

ACUTN/A

BCABN/A

Rule of 40

ACUT0.0

BCAB-299.0

EV/GP/RG

ACUTN/A

BCABN/A

Ticker research

View ACUT research View BCAB research

Metric	ACUT Accustem Sciences Inc	BCAB Bioatla Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$2M	$946K
Price	$0.15	$1.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.29x
EV/Sales	0.00x	0.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	4.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-0.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$9M
Revenue Growth (YoY)	N/A	-22.7%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-369.8%
Net Margin (TTM)	0.0%	-370.0%
FCF Margin (TTM)	N/A	-276.3%
Net Income (TTM)	$-2M	$-31M
FCF (TTM)	$-1M	$-23M
EPS (TTM)	-$0.10	-$18.93
ROE (TTM)	-21712.9%	-35792.0%
ROA (TTM)	-10530.0%	-26317.0%
ROIC (TTM)	-179413.5%	-35792.0%
Financial Health
Cash	$13K	$2M
Debt	$63K	$0
Net Cash/Debt	$-50K	$2M
Current Ratio (TTM)	0.02x	0.20x
Quick Ratio (TTM)	0.00x	0.17x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.63
52W Performance	-67.3%	-96.7%
YTD Performance	-75.6%	-94.4%
% from 52W High	-93.7%	-97.9%
% from 52W Low	26.0%	40.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.73x
FCF Yield (TTM)	-50.9%	-943.1%
Earnings Yield (TTM)	-69.8%	-1263.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-299.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View BCAB research

Valuation

P/S Ratio

ACUT

0.00x

BCAB

0.29x

EV/FCF

ACUT

-2.01x

BCAB

-0.04x

Growth & revenue

Revenue Growth TTM

BCAB

-22.7%

Forward Revenue Growth

ACUT

0.0%

BCAB

0.0%

Profitability & performance

Gross Margin

ACUT

0.0%

BCAB

0.0%

ROE

ACUT

-21712.9%

BCAB

-35792.0%

FCF Yield %

ACUT

-50.9%

BCAB

-943.1%

52-Week Performance

ACUT

-67.3%

BCAB

-96.7%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

BCAB

Bioatla Inc

Market Cap

ACUT$2M

BCAB$2M

Enterprise Value

ACUT$2M

BCAB$946K

Price

ACUT$0.15

BCAB$1.50

P/E Ratio

ACUTN/A

BCABN/A

P/S Ratio

ACUT0.00x

BCAB0.29x

EV/Sales

ACUT0.00x

BCAB0.11x

EV/EBITDA

ACUT0.00x

BCAB0.00x

P/B Ratio

ACUT2.97x

BCAB4.57x

P/FCF Ratio

ACUTN/A

BCABN/A

EV/FCF

ACUT-2.01x

BCAB-0.04x

PEG Ratio

ACUTN/A

BCABN/A

Forward P/E (NTM)

ACUTN/A

BCABN/A

Forward P/S (NTM)

ACUTN/A

BCABN/A

Revenue (TTM)

ACUT$0

BCAB$9M

Revenue Growth (YoY)

ACUTN/A

BCAB-22.7%

Forward Rev Growth

ACUT0.0%

BCAB0.0%

Gross Margin (TTM)

ACUT0.0%

BCAB0.0%

Operating Margin (TTM)

ACUT0.0%

BCAB0.0%

EBITDA Margin (TTM)

ACUT0.0%

BCAB-369.8%

Net Margin (TTM)

ACUT0.0%

BCAB-370.0%

FCF Margin (TTM)

ACUTN/A

BCAB-276.3%

Net Income (TTM)

ACUT$-2M

BCAB$-31M

FCF (TTM)

ACUT$-1M

BCAB$-23M

EPS (TTM)

ACUT-$0.10

BCAB-$18.93

ROE (TTM)

ACUT-21712.9%

BCAB-35792.0%

ROA (TTM)

ACUT-10530.0%

BCAB-26317.0%

ROIC (TTM)

ACUT-179413.5%

BCAB-35792.0%

Cash

ACUT$13K

BCAB$2M

Debt

ACUT$63K

BCAB$0

Net Cash/Debt

ACUT$-50K

BCAB$2M

Current Ratio (TTM)

ACUT0.02x

BCAB0.20x

Quick Ratio (TTM)

ACUT0.00x

BCAB0.17x

Debt/Equity (TTM)

ACUT0.27x

BCAB0.00x

Debt/Assets (TTM)

ACUT0.0%

BCAB0.0%

Interest Coverage (TTM)

ACUTN/A

BCABN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

BCAB0.00x

Beta

ACUT1.88

BCAB0.63

52W Performance

ACUT-67.3%

BCAB-96.7%

YTD Performance

ACUT-75.6%

BCAB-94.4%

% from 52W High

ACUT-93.7%

BCAB-97.9%

% from 52W Low

ACUT26.0%

BCAB40.2%

Asset Turnover (TTM)

ACUT0.00x

BCAB0.73x

FCF Yield (TTM)

ACUT-50.9%

BCAB-943.1%

Earnings Yield (TTM)

ACUT-69.8%

BCAB-1263.2%

Dividend Yield (TTM)

ACUTN/A

BCABN/A

Rule of 40

ACUT0.0

BCAB-299.0

EV/GP/RG

ACUTN/A

BCABN/A

Ticker research

View ACUT research View BCAB research

Metric	ACUT Accustem Sciences Inc	BCAB Bioatla Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$2M	$946K
Price	$0.15	$1.50
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.29x
EV/Sales	0.00x	0.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	4.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-0.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$9M
Revenue Growth (YoY)	N/A	-22.7%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-369.8%
Net Margin (TTM)	0.0%	-370.0%
FCF Margin (TTM)	N/A	-276.3%
Net Income (TTM)	$-2M	$-31M
FCF (TTM)	$-1M	$-23M
EPS (TTM)	-$0.10	-$18.93
ROE (TTM)	-21712.9%	-35792.0%
ROA (TTM)	-10530.0%	-26317.0%
ROIC (TTM)	-179413.5%	-35792.0%
Financial Health
Cash	$13K	$2M
Debt	$63K	$0
Net Cash/Debt	$-50K	$2M
Current Ratio (TTM)	0.02x	0.20x
Quick Ratio (TTM)	0.00x	0.17x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.63
52W Performance	-67.3%	-96.7%
YTD Performance	-75.6%	-94.4%
% from 52W High	-93.7%	-97.9%
% from 52W Low	26.0%	40.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.73x
FCF Yield (TTM)	-50.9%	-943.1%
Earnings Yield (TTM)	-69.8%	-1263.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-299.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View BCAB research